tariquidar

ATP binding cassette subfamily B member 1 ; Homo sapiens







77 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35565470 P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer Cells. 2022 May 9 1
2 33189788 Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells. 2021 Feb 10 3
3 33315404 Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates. 2021 Jan 4 1
4 33838147 Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2. 2021 Jun 25 3
5 33860196 Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells. 2021 Apr 9 1
6 33901197 Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein. 2021 2
7 33929088 Computer-Aided Search for 5-Arylideneimidazolone Anticancer Agents Able To Overcome ABCB1-Based Multidrug Resistance. 2021 Aug 5 1
8 34084427 Active participation of membrane lipids in inhibition of multidrug transporter P-glycoprotein. 2021 Apr 9 1
9 34208283 The Long-Term DEHP Exposure Confers Multidrug Resistance of Triple-Negative Breast Cancer Cells through ABC Transporters and Intracellular ROS. 2021 Jun 11 1
10 34220523 ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure. 2021 5
11 34617531 A multidrug-resistant P-glycoprotein assembly revealed by tariquidar-probe's super-resolution imaging. 2021 Oct 21 1
12 32056006 Restoration of MARCKS enhances chemosensitivity in cancer. 2020 Apr 1
13 32176509 Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. 2020 Apr 6 1
14 32253945 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers. 2020 Dec 2
15 32256321 Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions. 2020 1
16 32331368 Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. 2020 Apr 22 2
17 32634436 Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines. 2020 Oct 1
18 30237210 A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier. 2019 Apr 1
19 30391800 Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior. 2019 Jan 1
20 31048454 Coexpression of ABCB1 and ABCG2 in a Cell Line Model Reveals Both Independent and Additive Transporter Function. 2019 Jul 1
21 31379495 Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity. 2019 1
22 31441108 Discovery to solve multidrug resistance: Design, synthesis, and biological evaluation of novel agents. 2019 Oct 1
23 31515284 A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. 2019 Nov 1
24 31774117 ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators. 2019 Dec 19 1
25 31832814 Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography. 2019 Dec 12 2
26 29377455 LysoTracker and MitoTracker Red are transport substrates of P-glycoprotein: implications for anticancer drug design evading multidrug resistance. 2018 Apr 1
27 29631786 Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as P-glycoprotein-mediated multidrug resistance inhibitors. 2018 May 15 1
28 30041718 Folate-Targeted Redox-Responsive Polymersomes Loaded with Chemotherapeutic Drugs and Tariquidar to Overcome Drug Resistance. 2018 Oct 1 1
29 30453546 Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy. 2018 Nov 16 3
30 30562739 Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity. 2018 1
31 27738009 Assessment of P-Glycoprotein Transport Activity at the Human Blood-Retina Barrier with (R)-11C-Verapamil PET. 2017 Apr 1
32 28189725 Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer. 2017 Apr 15 1
33 28509582 Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance. 2017 Dec 3
34 26622052 Using the BacMam Baculovirus System to Study Expression and Function of Recombinant Efflux Drug Transporters in Polarized Epithelial Cell Monolayers. 2016 Feb 2
35 26913287 3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS. 2016 Feb 1
36 26989076 β-casein nanovehicles for oral delivery of chemotherapeutic Drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells. 2016 Apr 26 1
37 27522191 Intracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing). 2016 Aug 14 1
38 27676469 Phenyltetrazolyl-phenylamides: Substituent impact on modulation capability and selectivity toward the efflux protein ABCG2 and investigation of interaction with the transporter. 2016 Nov 29 1
39 25669913 Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study. 2015 May 2
40 25855895 HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). 2015 May 14 1
41 26125482 Multiple Drug Transport Pathways through Human P-Glycoprotein. 2015 Jul 21 1
42 26202880 Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography. 2015 Sep 8 2
43 26486517 Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors. 2015 Dec 2
44 26507655 Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein. 2015 Dec 4 3
45 24478983 Small and Innovative Molecules as New Strategy to Revert MDR. 2014 1
46 25330312 Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel. 2014 Oct 1
47 25456855 Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation. 2014 Dec 15 4
48 23063413 Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activity. 2013 Jan 1 1
49 23146816 Pharmacokinetics of single ascending doses of the P-glycoprotein inhibitor tariquidar in healthy subjects. 2013 3
50 23340958 Retrospective analysis of P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier in humans. 2013 Apr 1